✦ LIBER ✦

Current status of pyrazoloacridine as an anticancer agent

✍ Scribed by Alex A. Adjei

Book ID: 110233446
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 64 KB
Volume: 17
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1006242321596

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current status of development of antican

Current status of development of anticancer agents in Japan

✍ Tomohiro Morita; Akiko Hori; Hiroto Narimatatsu; Tetsuya Tanimoto; Masahiro Kami 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 148 KB

Current status of development of antican

Current status of development of anticancer agents in Japan

✍ Tomohiro Morita; Akiko Hori; Hiroto Narimatsu; Tetsuya Tanimoto; Masahiro Kami 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 82 KB

Current development of mTOR inhibitors a

Current development of mTOR inhibitors as anticancer agents

✍ Faivre, Sandrine; Kroemer, Guido; Raymond, Eric 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 777 KB

Discovery and development of SAHA as an

Discovery and development of SAHA as an anticancer agent

✍ Marks, P A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Thymidine as an anticancer agent, alone

Thymidine as an anticancer agent, alone or in combination

✍ Peter H. Ellims 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 667 KB

The value of thymidine as a cytotoxic drug alone or in combination with other pyrimidine antimetabolites has received considerable attention in recent years. In this paper, the biochemical basis for the cytotoxicity of thymidine and its interaction with other pyrimidine antimetabolites is described.

Paclitaxel as an anticancer agent: isola

Paclitaxel as an anticancer agent: isolation, activity, synthesis and stability

✍ Nikolic, Vesna ;Savic, Ivan ;Savic, Ivana ;Nikolic, Ljubisa ;Stankovic, Mihajlo 📂 Article 📅 2011 🏛 Walter de Gruyter GmbH 🌐 English ⚖ 500 KB